UMDF Connect

Ask the Mito Doc – Kygevvi

Ask the Mito Doc - Special Edition: FDA Approval of Kygevvi for TK2d    All answers today are based on personal experience of the participants. As always, please consult your personal physician prior to taking any action.Ask the Mito Doc - Special Edition: FDA...

read more

Ask the Mito Doc – November 2025; Q&A

Ask the Mito Doc - November 2025 Q&A    All answers today are based on personal experience of the participants. As always, please consult your personal physician prior to taking any action.Topic: Genetic Testing in Mitochondrial Disease - What Patients and...

read more

FDA Approves First-Ever TK2d Therapy

11/3/25, 5pm EST -- Earlier today, the U.S. Food and Drug Administration (FDA) approved UCB’s Kygevvi (doxecitine and doxribtimine) to treat the mitochondrial disease thymidine kinase 2 deficiency (TK2d). “It’s hard to put into words what today’s decision means for...

read more

Ask the Mito Doc – October 2025; Q&A

Ask the Mito Doc - October 2025 Q&A    All answers today are based on personal experience of the participants. As always, please consult your personal physician prior to taking any action.Topic: Fact or Fiction: Separating Science from Speculation in Mitochondrial...

read more